Anthocyanins Genetics and Genomics

Carrot Anthocyanins Genetics and Genomics: Standing and Views to Enhance Its Software for the Meals Colorant Trade

Purple or black carrots (Daucus carota ssp. sativus var. atrorubens Alef) are characterised by their darkish purple- to black-colored roots, owing their look to excessive anthocyanin concentrations.
In recent times, there was rising curiosity in using black carrot anthocyanins as pure meals dyes. Black carrot roots include giant portions of mono-acylated anthocyanins, which impart a measure of heat-, light- and pH-stability, enhancing the color-stability of meals merchandise over their shelf-life.
The genetic pathway controlling anthocyanin biosynthesis seems properly conserved amongst land vegetation; nevertheless, totally different variants of anthocyanin-related genes between cultivars leads to tissue-specific accumulations of purple pigments.
Thus, broad genetic variations of anthocyanin profile, and tissue-specific distributions in carrot tissues and organs, could be noticed, and the ratio of acylated to non-acylated anthocyanins varies considerably within the purple carrot germplasm.
Moreover, anthocyanins synthesis can be influenced by a variety of exterior elements, equivalent to abiotic stressors and/or chemical elicitors, straight affecting the anthocyanin yield and stability potential in meals and beverage functions.
On this examine, we critically evaluation and talk about the present information on anthocyanin range, genetics and the molecular mechanisms controlling anthocyanin accumulation in carrots. We additionally present a view of the present information gaps and development wants as regards growing and making use ofrevolutionary molecular instruments to enhance the yield, product efficiency and stability of carrot anthocyanin to be used as a pure meals colorant.
cd1234567890
cd1234567890

Anti-CXCL8 / IL-8 Reference Antibody (Genentech anti-IL-8)

E24CHA784 100 μg
EUR 225
Description: Available in various conjugation types.

Human IL-8

90258-A 5 µg
EUR 130
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli.

Human IL-8

90258-B 25 µg
EUR 205
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli.

human IL-8

M851530020 1 unit
EUR 843.16

Anti-IL-8 Antibody

A2062-100 100 µg
EUR 472.8

Anti-IL-8 Antibody

A00423 1 mL
EUR 1444.8
Description: Rabbit Polyclonal IL-8 Antibody. Validated in IP, WB and tested in Human.

Anti-IL-8 Antibody

R1511-15 100ul
EUR 189

Anti-IL-8 Antibody

ER1706-67 100ul
EUR 189
Description: Interleukin 8 (IL-8 or chemokine (C-X-C motif) ligand 8, CXCL8) is a chemokine produced by macrophages and other cell types such as epithelial cells, airway smooth muscle cells and endothelial cells. IL-8, also known as neutrophil chemotactic factor, has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also stimulates phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis. In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, such as increases in intracellular Ca2+, exocytosis (e.g. histamine release), and the respiratory burst. IL-8 can be secreted by any cells with toll-like receptors that are involved in the innate immune response and has been demonstrated to be a signatory chemokine of CR2+ naive T cells, also known as recent thymic emigrants. Usually, it is the macrophages that see an antigen first, and thus are the first cells to release IL-8 to recruit other cells. Both monomer and homodimer forms of IL-8 have been reported to be potent inducers of the chemokine receptors CXCR1 and CXCR2. The homodimer is more potent, but methylation of Leu25 can block the activity of homodimers.

Anti-IL-8 Antibody

ER1901-61 100ul
EUR 189
Description: IL-8, also known as neutrophil chemotactic factor, has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also stimulates phagocytosis once they have arrived. IL-8 is also known to be a potent promoter of angiogenesis. In target cells, IL-8 induces a series of physiological responses required for migration and phagocytosis, such as increases in intracellular Ca2+, exocytosis (e.g. histamine release), and the respiratory burst.IL-8 can be secreted by any cells with toll-like receptors that are involved in the innate immune response. Usually, it is the macrophages that see an antigen first, and thus are the first cells to release IL-8 to recruit other cells. Both monomer and homodimer forms of IL-8 have been reported to be potent inducers of the chemokine receptors CXCR1 and CXCR2. The homodimer is more potent, but methylation of Leu25 can block the activity of homodimers.

Anti-IL-8 antibody

STJ97710 200 µl
EUR 236.4
Description: Mouse monoclonal to IL-8.

Anti-IL-8 antibody

STJ97717 200 µl
EUR 236.4
Description: Mouse monoclonal to IL-8.

Anti-IL-8 antibody

STJ97720 200 µl
EUR 236.4
Description: Mouse monoclonal to IL-8.

Anti-IL-8 antibody

STJ98175 100 µl
EUR 280.8
Description: Mouse monoclonal to IL-8.

Anti-IL-8 Antibody

Y123169 100 µl
EUR 320

anti-IL-8 (3E4D8)

LF-MA30011 100 ul
EUR 448.8
Description: Mouse Monoclonal to IL-8

human-anti-human-IL-8-mAb(1H)

E409C16-hA100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

human-anti-human-IL-8-mAb(2H)

E409C16-hB100 Inflammation-Storm-Antibodies
EUR 276.5
Description: Inflammation Storm Antibodies

mAb mouse anti-human IL-8

CT264 0.5 mg
EUR 312

mouse anti-human IL-8 mAb

E409C16-m100 100μL
EUR 395
Description: Available in various conjugation types.

IL-8/CXCL8, Human

HY-P7224 50ug
EUR 596.4

Human IL-8 Protein

abx060803-25ug 25 ug
EUR 644.4

Human IL-8 Protein

abx060804-25ug 25 ug
EUR 644.4

Human IL-8 protein

PRP1022-100ug 100 μg
EUR 449
Description: Human IL-8 protein, expressed in E. coli

Human IL-8 protein

PRP1022-10ug 10 μg
EUR 59
Description: Human IL-8 protein, expressed in E. coli

Human IL-8 protein

PRP1022-1mg 1 mg
EUR 2609
Description: Human IL-8 protein, expressed in E. coli

Human IL-8 protein

PRP1022-50ug 50 μg
EUR 249
Description: Human IL-8 protein, expressed in E. coli

Rabbit anti-IL-8 Antibody

YLD4345-100ul 100 ul
EUR 320
Description: Rabbit polyclonal antibody to IL-8

Rabbit anti-IL-8 Antibody

YLD4345-50ul 50 ul
EUR 200
Description: Rabbit polyclonal antibody to IL-8

Rabbit anti-IL-8 Antibody

DL90596A-100ul 100 ul
EUR 270
Description: CXCL8; Interleukin-8; IL-8; C-X-C motif chemokine 8; Emoctakin; Granulocyte chemotactic protein 1; GCP-1; Monocyte-derived neutrophil chemotactic factor; MDNCF; Monocyte-derived neutrophil-activating peptide; MONAP; Neutrophil-activating protein 1; NAP-1; Protein 3-10C; T-cell chemotactic factor

Rabbit anti-IL-8 Antibody

DL90596A-50ul 50 ul
EUR 189
Description: CXCL8; Interleukin-8; IL-8; C-X-C motif chemokine 8; Emoctakin; Granulocyte chemotactic protein 1; GCP-1; Monocyte-derived neutrophil chemotactic factor; MDNCF; Monocyte-derived neutrophil-activating peptide; MONAP; Neutrophil-activating protein 1; NAP-1; Protein 3-10C; T-cell chemotactic factor

Anti-IL-8 Monoclonal Antibody

A00423-1 100ul
EUR 476.4
Description: Mouse Monoclonal Antibody for IL-8 Antibody (CXCL8) detection. Tested with IHC in Human, Mouse, Rat.

Recombinant Human IL-8

P0180 100ug
EUR 626.83
Description: Recombinant Human protein for IL-8

Recombinant Human IL-8

SJB05-01 25µg/vial
EUR 342

Recombinant Human IL-8

6487 5 µg
EUR 194

Human Interleukin-8 (IL-8) Antibody (Biotin Conjugate)

13102-05021 150 ug
EUR 313.2

Anti-Human IL-8 (I8-S2) Antibody

Y052802 100 µg
EUR 490

Human IL-8 ELISA antibody pair

CT748-10 10-plate
EUR 656.4

Human IL-8 ELISA antibody pair

CT748-20 20-plate
EUR 1118.4

Anti-Human IL-8 Rabbit Polyclonal Antibody

TA328221 100 µg Ask for price

human DIAplex Human Inflammation - IL-8, IL-17a,

M880130004 1 unit
EUR 681.23

Rabbit anti-Human IL-8 mAb (CAP)

RM17646 100μg Ask for price

Rabbit anti-Human IL-8 mAb (DET)

RM17647 100μg Ask for price

Rabbit anti-Human IL-8 mAb (CAP)

RM17648 100μg Ask for price

Rabbit anti-Human IL-8 mAb (DET)

RM17649 100μg Ask for price

Human IL-8 Antibody (Biotin Conjugate)

33486-05121 150 ug
EUR 442.8

Human Interleukin 8 (IL-8) CLIA Kit

abx195916-96tests 96 tests
EUR 990

Human Interleukin 8,IL-8 ELISA KIT

201-12-0090 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human Interleukin 8, IL-8 ELISA KIT

CSB-E04641h-24T 1 plate of 24 wells
EUR 198
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid (CSF), tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human Interleukin 8, IL-8 ELISA KIT

1-CSB-E04641h
  • EUR 600.00
  • EUR 4082.40
  • EUR 2184.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid(CSF), tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Interleukin 8(IL-8)ELISA Kit

GA-E0129HM-48T 48T
EUR 346.8

Human Interleukin 8(IL-8)ELISA Kit

GA-E0129HM-96T 96T
EUR 559.2

Human IL-8(Interleukin 8) ELISA Kit

EH0205 96T
EUR 571.5
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml

Human IL-8 (Interleukin 8) ELISA Kit

EKE60046-5x96T 5x96T
EUR 2667.6

Human IL-8 (Interleukin 8) ELISA Kit

EKE60046-96T 96T
EUR 561.6

Human IL-8(Interleukin 8) ELISA Kit

EKF57074-48T 48T
EUR 396.9

Human IL-8(Interleukin 8) ELISA Kit

EKF57074-5x96T 5x96T
EUR 2693.25

Human IL-8(Interleukin 8) ELISA Kit

EKF57074-96T 96T
EUR 567

Human Interleukin 8,IL-8 ELISA KIT

EKC40086-48T 48T
EUR 328.86

Human Interleukin 8,IL-8 ELISA KIT

EKC40086-5x96T 5x96T
EUR 2231.55

Human Interleukin 8,IL-8 ELISA KIT

EKC40086-96T 96T
EUR 469.8

Human Interleukin 8(IL-8)ELISA Kit

NSL1931Hu 96 wells
EUR 468

Human Interleukin 8 (IL-8) ELISA Kit

AE38177HU-48Tests 48 Tests
EUR 200
Description: Human (Homo sapiens)

Human Interleukin 8 (IL-8) ELISA Kit

AE38177HU-96Tests 96 Tests
EUR 360
Description: Human (Homo sapiens)

Human Interleukin 8(IL-8)ELISA Kit

QY-E04259 96T
EUR 433.2

Human Interleukin 8,IL-8 ELISA Kit

SL1004Hu 96 Tests
EUR 468

Human Interleukin 8,IL-8 ELISA KIT

YLA1210HU-48T 48T
EUR 435

Human Interleukin 8,IL-8 ELISA KIT

YLA1210HU-96T 96T
EUR 562.5

Human IL-8(Interleukin 8) ELISA Kit

E39EH0205 96T
EUR 595

Human Interleukin 8(IL-8) Elisa Kit

EK610269 96 Wells
EUR 0.1

Human Interleukin 8(IL-8) Elisa Kit

EK710269 96 Wells
EUR 0.77

Human Interleukin-8 (IL-8) ELISA Kit

LF-EK60006 1×96T
EUR 948

Human Interleukin-8 (IL-8) AssayLite Antibody (RPE Conjugate)

13102-05051 150 ug
EUR 513.6

Human Interleukin-8 (IL-8) AssayLite Antibody (APC Conjugate)

13102-05061 150 ug
EUR 513.6

Human Interleukin-8 (IL-8) AssayLite Antibody (FITC Conjugate)

13102-05041 150 ug
EUR 513.6

Human Interleukin-8 (IL-8) AssayLite Antibody (PerCP Conjugate)

13102-05071 150 ug
EUR 565.2

IL-8 (72 a.a.), Human

E34M010H 5 μg
EUR 155
Description: Recombinant Human Cytotoxic T-lymphocyte Protein 4 is produced by our Mammalian expression system and the target gene encoding Lys36-Asp161 is expressed with a Flag tag at the C-terminus.

human IL-8 His tag

E410A07-100 100μg
EUR 1152

Anti‐Human IL‐17A

E2790213 100ul
EUR 225
Description: Available in various conjugation types.

Human IL-8 ELISA kit

CT212A 5-plate
EUR 554.4

Human IL-8 ELISA kit

LF-EK50165 1×96T
EUR 777.6

IL-8 ELISA KIT|Human

EF003990 96 Tests
EUR 826.8

Human IL-8 ELISA Kit

EHI0063 96Tests
EUR 625.2

IL-8/CXCL8, 72a.a., Human

HY-P7380 50ug
EUR 596.4

IL-8 (Human) ELISA Kit

K4169-100 each
EUR 874.8

Characterization of Anti-Inflammatory and Antioxidant Constituents from Scutellaria baicalensis Utilizing LC-MS Coupled with a Bioassay Technique

An efficient and beforehand demonstrated screening technique for energetic constituents in pure <em>merchandise</em> utilizing LC-MS coupled with a bioassay was reported in our earlier research.
With this, the present investigation tried to determine bioactive constituents of <i>Scutellaria baicalensis</i> via LC-MS coupled with a bioassay.
Peaks at broadly 17-20 and 24-25 min on the MS chromatogram displayed an inhibitory impact on NO manufacturing in lipopolysaccharide-induced BV2 microglia cells.
Equally, peaks at roughly 17-19 and 22 min confirmed antioxidant exercise with an 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)/2,2-diphenyl-1- picrylhydrazyl (DPPH) assay.
For affirmation of LC-MS coupled with a bioassay, 9 compounds (<b>1</b>-<b>9</b>) have been remoted from an MeOH extract of <i>S. baicalensis</i>. As we predicted, compounds <b>1</b>, <b>8</b>, and <b>9</b> considerably lowered lipopolysaccharide (LPS)-induced NO manufacturing in BV2 cells.
Likewise, compounds <b>5</b>, <b>6</b>, and <b>8</b> exhibited free radical-scavenging actions with the ABTS/DPPH assay. As well as, the structural similarity of the principle elements was confirmed by analyzing the whole extract and EtOAc fractions via <em>molecular</em> networking.
Total, the outcomes recommend that the strategy comprised of LC-MS coupled with a bioassay can successfully predict energetic compounds with out an isolation course of, and the outcomes of <em>molecular</em> networking predicted that different elements across the energetic compound node can also be energetic.

Polymer-Derived Heteroatom-Doped Porous Carbon Supplies

Heteroatom-doped porous carbon supplies (HPCMs) have discovered in depth functions in adsorption/separation, natural catalysis, sensing, and power conversion/storage.
The even handed alternative of carbon precursors is essential for the manufacture of HPCMs with particular usages and maximization of their capabilities. On this regard, polymers as precursors have demonstrated nice promise due to their versatile molecular and nanoscale constructions, modulatable chemical composition, and wealthy processing strategies to generate textures that, together with correct solid-state chemistry, could be maintained all through carbonization.
This Overview comprehensively surveys the progress in polymer-derived practical HPCMs by way of the right way to produce and management their porosities, heteroatom doping results, and morphologies and their associated use.
First, we summarize and talk about artificial approaches, together with laborious and delicate templating strategies in addition to direct synthesis methods using polymers to manage the pores and/or heteroatoms in HPCMs. Second, we summarize the heteroatom doping results on the thermal stability, digital and optical properties, and floor chemistry of HPCMs.
Particularly, the heteroatom doping impact, which includes each single-type heteroatom doping and codoping of two or extra kinds of heteroatoms into the carbon community, is mentioned.
Contemplating the significance of the morphologies of HPCMs of their utility spectrum, potential decisions of appropriate polymeric precursors and methods to exactly regulate the morphologies of HPCMs are offered.
Lastly, we present our perspective on the right way to predefine the constructions of HPCMs through the use of polymers to comprehend their potential functions within the present fields of power era/conversion and environmental remediation.
We imagine that these analyses and deductions are helpful for a systematic understanding of polymer-derived carbon supplies and can function a supply of inspiration for the design of future HPCMs.

Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG, aff pure

FLT12-M 100 ug
EUR 578.4

Mouse Monoclonal Anti-human FLT-1/VEGFR-1 IgG, aff pure

FLT14-M 100 ug
EUR 578.4

VEGFR-3/Flt-4

JP27779 96
EUR 611

Rabbit Anti-Mouse FLT-1/VEGFR-1 (279-299aa) IgG, aff pure

FLT15-A 100 ul
EUR 578.4

Human VEGFR-3 / Flt-4 GENLISA ELISA

KBH0215 1 x 96 wells
EUR 286

Rabbit Anti-Mouse FLT-4/VEGFR-3 IgG #1, aff pure

FLT41-A 100 ug
EUR 578.4

Mouse FLT-4/VEGFR-3 Control/blocking peptide #1

FLT41-P 100 ug
EUR 196.8

Rabbit Anti-Human FLT-4/VEGFR-3 IgG #2, aff pure

FLT42-A 100 ug
EUR 578.4

Human FLT-4/VEGFR-3 control/blocking peptide #2

FLT42-P 100 ug
EUR 196.8

VEGFR-1/Flt1/ Rat VEGFR- 1/ Flt1 ELISA Kit

ELA-E0147r 96 Tests
EUR 1063.2

Human VEGFR1/Flt-1 ELISA KIT

E42EH-249 96T/48T Ask for price

Human VEGFR-1/Flt1 ELISA Kit

EHV0045 96Tests
EUR 625.2

Recombinant human VEGFR1/Flt-1 Protein

RP01188 5 μg
EUR 163.2

Anti-VEGFR-1/FLT-1 antibody

PAab09393 100 ug
EUR 426

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCA0658-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), APC conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCA0659-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), APC conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC800658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC800658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC800659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC800659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC810658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC810658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF680R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC810659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC810659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF680R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC940658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF594 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC940658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF594 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC940659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF594 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC940659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF594 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC700658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF770 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC700658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF770 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC700659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF770 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC700659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF770 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC880658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF488A conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC880658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF488A conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC880659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF488A conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC880659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF488A conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC040658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405S conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC040658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405S conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC040659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405S conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC040659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405S conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC400658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF640R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC400658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF640R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC400659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF640R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC400659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF640R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC050658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405M conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC050658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF405M conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC050659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405M conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC050659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF405M conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCB0658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Biotin conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCB0658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Biotin conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCB0659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Biotin conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCB0659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Biotin conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCAP0658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCAP0658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCAP0659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCAP0659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCR0658-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), RPE conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCR0659-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), RPE conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCP0658-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), PerCP conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCP0659-250 250uL
EUR 459.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), PerCP conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNUM0658-50 50uL
EUR 474
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), 1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNUM0659-50 50uL
EUR 474
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), 1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCH0658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNCH0658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCH0659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNCH0659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNUB0658-100 100uL
EUR 250.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Concentration: 0.2mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNUB0658-500 500uL
EUR 549.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), Concentration: 0.2mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNUB0659-100 100uL
EUR 250.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Concentration: 0.2mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNUB0659-500 500uL
EUR 549.6
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), Concentration: 0.2mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC550658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF555 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC550658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF555 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC550659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF555 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC550659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF555 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC610658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF660R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC610658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF660R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC610659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF660R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC610659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF660R conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC680658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF568 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC680658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF568 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC680659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF568 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC680659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF568 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC470658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF647 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC470658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF647 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC470659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF647 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC470659-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF647 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC430658-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF543 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/658) Antibody

BNC430658-500 500uL
EUR 652.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/658), CF543 conjugate, Concentration: 0.1mg/mL

VEGFR1 / Flt-1(FLT1/659) Antibody

BNC430659-100 100uL
EUR 238.8
Description: Primary antibody against VEGFR1 / Flt-1(FLT1/659), CF543 conjugate, Concentration: 0.1mg/mL